Table 1. Characteristics of patients with refractory VKC before treatment with topical 0.005% tacrolimus eye drop and their final visual acuity after the treatment.

Case no.	Gender/age (years)	VKC duration (years)	BSCVA		Follow-up (months)
			Before R-L	Final R-L
1	M/23	15	20/30–20/30	20/25–20/25	15
2	F/24	17	20/30–20/30	20/30–20/30	14
3	M/16	7	20/25–20/25	20/25–20/25	13
4	M/26	15	20/200–20/100	20/70–20/50	10
5	M/38	25	20/50–20/40	20/30–20/30	10
6	M/11	7	20/25–20/30	20/25–20/30	11
7	M/19	8	20/25–20/30	20/25–20/30	10
8	M/18	8	20/30–20/30	20/25–20/20	9
9	M/22	9	20/20–20/20	20/20–20/20	9
10	M/16	10	20/25–20/25	20/25–20/25	6

Abbreviations: BSCVA, best spectacle-corrected visual acuity; L, left; R, right; VKC, vernal keratoconjunctivitis.